Prediction Case File
YouTubeEvaluation Complete

Book Your Free Portfolio Review Call: https://felixfriends.org/review

1 extracted signal · 1 resolved · 0 still active

Felix & Friends (Goat Academy) profile imageFelix & Friends (Goat Academy)19 Aug 2025, 23:00 UTC
Video preview for Book Your Free Portfolio Review Call: https://felixfriends.org/review
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis identifies Tempus AI (TEM) as a precision medicine company, the analysis shows a positive outlook for its stock (TEM), current at 78.57, with the goal to break the former top resistance at 92. With a high volume, the analysis suggests a sweet set up. To set a stop loss with generous volume. The analysis consider a minimum competition but with a long term durability over short spikes with 25% for 10 years.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Felix & Friends (Goat Academy)

Tracked signals
338
Historical success
59.2%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.